http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103012265-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_078cb8366425c7f7bb46338421d23406
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16
filingDate 2012-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b0ed8688b1febdee564700ded77b48e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fa6203fe476364a10912ca81044462a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83d63602cf768fc52f3e7b670e835d1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c734fa68ea0a0d3c2d87992b4c60158e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e069914601b8151de5f0eb58911f6a7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab17765e0a67fc1d09bd370779f2055d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4d42aa05f7d30bd16181d358fdd4e77
publicationDate 2013-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103012265-A
titleOfInvention A kind of preparation method of 7-chloro-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine
abstract The present invention relates to a preparation method of 7-chloro-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine, 7-chloro-5-oxo-2,3 , 4,5-tetrahydro-1H-1-benzazepine is an important intermediate for the preparation of arginine vasopressin V2 receptor antagonist tolvaptan. This preparation method uses 2-amino-5-chlorobenzoic acid methyl ester and 4-bromobutyric acid ethyl ester as starting materials, generates secondary amine under the action of acid-binding agent, and then undergoes Dickmann condensation and hydrolysis reaction to obtain the target Compound 7-Chloro-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine. Compared with the existing method, the method has fewer reaction steps, is easy to operate, has good product purity, and greatly improves the yield, thereby reducing production cost and increasing income.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105315212-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105315169-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105315169-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105315212-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104829533-A
priorityDate 2012-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102093293-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467002821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410271420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467860800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22903483

Total number of triples: 26.